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VALIDATION OF A RAPID STOOL ANTIGEN TEST FOR DIAGNOSIS OF Helicobacter pylori INFECTION
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SUMMARY
The aim of this study was to validate the rapid lateral flow Helicobacter pylori stool antigen test (One step H. pylori antigen test, 
ACON laboratories, San Diego, USA; Prime diagnostics, São Paulo), using 13C-Urea Breath Test as the gold standard for H. pylori 
infection diagnosis. A total of 98 consecutive patients, asymptomatic or dyspeptic, entered the study. Sixty-nine were women, with a 
mean age of 45.76 ± 14.59 years (14 to 79 years). In the H. pylori-positive group, the rapid stool antigen test detected H. pylori antigen 
in 44 of the 50 positive patients (sensitivity 88%; 95% CI: 75.7-95.5%), and six false-negative; and in the H. pylori-negative group 42 
presented negative results (specificity 87.5%; 95% CI: 74.7-95.3%), and six false-positive, showing a substantial agreement (Kappa 
Index = 0.75; p < 0.0001; 95% CI: 0.6-0.9). Forty four of fifty patients that had positive stool antigen were H. pylori-positive, the PPV 
of the stool antigen test was 88% (95% CI: 75.7-95.5%), and 42 patients with negative stool antigen test were H. pylori-negative, the 
NPV of the stool antigen test was 87.5% (95% CI: 74.7-95.3%). We conclude that the lateral flow stool antigen test can be used as 
an alternative to breath test for H. pylori infection diagnosis especially in developing countries.
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INTRODUCTION
Helicobacter pylori (H. pylori), spiral or curved gram-negative 
microaerophilic, flagellate bacilli has been considered the etiological 
cause of gastritis, peptic ulcer disease21,24 and associated with the 
development of gastric cancer25.
The prevalence of H. pylori infection is different worldwide, 
depending on the socioeconomic status and sanitation conditions1; in the 
developed countries being under 40% and more than 80% in developing 
countries16, including Brazil where the prevalence varies from 65.6% in 
the city of Sao Paulo that has a high standard of living34, to 87% in the 
poor urban areas of Fortaleza, northeastern Brazil29.
The diagnosis of H. pylori infection can be achieved by invasive 
methods such as urease test, which has 97.4% sensitivity and 100% 
specificity32, widely used and performed in the endoscopy suite as a 
rapid indirect test to confirm the presence of H. pylori in biopsy samples, 
and histology of the Modified Giemsa stained gastric biopsies (96.2% 
sensitivity)18. Non-invasive methods, 14C- urea breath test (14C-UBT)22,23 
and 13C urea breath test (13C-UBT), are considered gold standard19. 
Recently, a noninvasive diagnostic test based on the detection of H. pylori 
stool antigen has been developed. Some H. pylori stool antigen tests 
that use polyclonal antibodies to H. pylori have shown heterogeneous 
results2,12,17. More recently, novel stool antigen tests based on monoclonal 
antibodies which could increase the accuracy of this test, have been 
developed 2,8,12,14,15,33.
 The non-radioactive isotope 13C-UBT is preferable to 14C-UBT3; 
however, the acquisition of Infrared has a cost that most places cannot 
afford, and that makes the stool antigen a cheaper alternative choice 
for eradication control2,15. It was recommended by the Maastricht III 
Consensus Report as a non-invasive test19. 
The stool antigen tests based on immunoassay (ELISA) have been 
tested in several laboratories of the world, including in Brazil4,26-28, and 
the results have been satisfactory. In Brazil, previous validation of a 
monoclonal stool antigen test for diagnosis of H. pylori was reported 
in children27; however, the stool antigen test based on lateral flow 
chromatography has not yet been tested in adults. The major advantage 
of these tests is the cost, when compared to 13C-UBT and the possibility 
of being performed in any laboratory10,14,15,17.
The rapid stool antigen test (ACON laboratories, Inc, San Diego, 
USA) is a rapid 10-min assay based on lateral flow chromatography with 
polyclonal antibodies that detect H. pylori antigens present in human 
stool. Thus, the aim of this study was to evaluate the rapid Helicobacter 
pylori stool antigen test, using 13C-UBT as the “gold standard” method 
for H. pylori infection diagnosis.
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MATERIAL AND METHODS
Patients: This study was approved by the local Ethics Committee 
(CAPPesq 0311/2009). A total of 98 consecutive patients, asymptomatic 
or dyspeptic, entered the study after providing written informed consent. 
Sixty-nine were women with a mean age of 45.76 ± 14.59 years (14 to 
79 years). None had taken antibiotics at least one month before the test 
or acid secretor inhibitors in the previous ten days. The interval between 
the tests for H. pylori infection diagnosis did not exceed 14 days. The 
stools were fresh and processed immediately. Patients were instructed 
to store the stools at 4-16 °C until arrival at the laboratory.
H. pylori status: The H. pylori status was based on the results of 
13C-Urea breath test, and 13C-Urea breath test was considered the gold 
standard to ascertain the H. pylori-positive and the H. pylori-negative 
groups.
13C-Urea breath (UBT): Patients had to avoid smoking and sparkling 
water or soft drinks on the day of the test and observe a 4-hour fast. 13C-Urea 
breath was performed using acid meal, composed of 75 mg of 13C-labeled 
urea dissolved in 200 mL of orange juice. Breath samples were collected 
in aluminized plastic bag to determine the baseline value before ingestion 
of acid meal and at 30 minutes after ingestion of the juice. Breath samples 
were analyzed by infrared spectroscopy (IRIS DOC, Wagner Analysen - 
Technik, Bremen, Germany). A DOB (Delta over baseline-value) ≥ 4.0‰ 
was considered positive for H. pylori infection, as previously described17.
H. pylori stool antigen test by Lateral Flow Immunoassay: 
Specimens were tested using the stool antigen test (One step H. pylori 
antigen test device, IHP-602, ACON laboratories, Inc, San Diego, USA; 
Prime diagnostics, São Paulo, Brazil) according to the manufacturer’s 
instructions (94.9%-100% sensitivity and 95.1-100% specificity, 
according to the manufacturer). Briefly, small samples of stool specimens 
collected from three different parts of the stool sample were transferred 
to a vial with diluent, vigorously agitated and after two minutes of resting 
the tube, dropping around two to three drops into the round window of 
the test cassette. Reading was made after 10 minutes of incubation at 
room temperature, and based on the appearance of colored lines across 
the central window of the cassette, two lines, C (control) and T (test), 
indicated positive test, only one line in C indicated negative result. A 
pale colored line in T was also considered positive.
Statistical analysis: The statistical analysis was performed by Kappa 
index measure of agreement of diagnostic tests, and Chi-square using 
SPSS. Confidence intervals were calculated by Exact Binomial Test with 
program R 2.10.1.
RESULTS
Fifty of ninety-eight patients were positive according to UBT, being 
defined as H. pylori-positive, and 48 patients were negative according to 
UBT and considered H. pylori-negative. In the H. pylori-positive group, the 
rapid stool antigen test detected H. pylori antigen in 44 of the 50 positive 
patients (sensitivity 88%; 95% confidence interval (CI): 75.7 - 95.5%), and 
six false-negative; and in the H. pylori-negative group, 42 presented negative 
results (specificity 87.5%; 95% CI: 74.7 - 95.3%), and six false-positives, 
showing a substantial agreement (Kappa Index = 0.75; p < 0.0001; CI: 0.6 - 
0.9). Considering that 44 patients of 50 that had positive stool antigen were 
H. pylori-positive according to UBT, the positive predictive value of the 
stool antigen test was 88% (95% CI: 75.7 - 95.5%), and that 42 patients with 
negative stool antigen test were H. pylori-negative, the negative predictive 
value of the stool antigen test was 87.5% (95% CI: 74.7 - 95.3%), as shown in 
Table 1. Among six patients that had positive stool antigen test and negative 
UBT, four of them were eradication control.
DISCUSSION
H. pylori colonizes the human stomach during childhood26 and 
survives in the human stomach, the only niche known to date, for the 
lifetime of the carrier5. In most of the individuals H. pylori infection may 
be asymptomatic, causing chronic gastritis. Around 20% to 30% of the 
infected individuals may develop peptic ulcer disease20, and less than 2% 
gastric cancer16. Gastrointestinal endoscopy has been widely performed 
for gastrointestinal disorders and H. pylori infection diagnosis20. 
Nonetheless, the Maastricht III consensus report recommended in primary 
care, a test and treat strategy using a noninvasive test in adult patients 
under the age of 45 with persistent dyspepsia. The urea breath test, stool 
antigen tests, and serological kits with a high accuracy are non-invasive 
exams which should be used for the diagnosis of H. pylori infection19.
For eradication control, ideally after three months of treatment, the 
breath test rapidly confirms the disappearance of H. pylori31, unlike the 
serological techniques, which need a prolonged period of time to confirm 
the eradication effect. Thus, because antibody titers can take up to six 
months to fall after successful treatment, serological tests cannot readily 
be used to assess the efficacy of H. pylori eradication regimens shortly 
after treatment8. 
Even though the radiation exposure from 14C-urea breath test is 
less than 1% of that received from an upper gastrointestinal series22, 
the cost of a β counter is low, and the test has 100% specificity and 
sensitivity23, the long half life (5.730 years)3 of 14C restricts its use due 
to the environmental protection policy. That means 13C-urea breath test 
and the stool antigen test are the only choices of non-invasive methods 
for H. pylori-infection eradication control.
The development of non-dispersive isotope selective infrared 
spectrometers opened up a lower-priced analytical alternative for high-
resolution mass spectrometers with sensitivity and specificity of 95% in 
multiple studies and a meta-analysis including more than 3500 patients3. 
However, most of the Health Centers in Brazil cannot afford to pay 
for infrared spectrometers in foreign currency, even though the cost of 
Table 1
Performance of the stool antigen test using UBT to define H. pylori-negative and H. pylori-positive groups
Group Method True positive True negative False positive False negative Sensitivity Specificity PPV NPV
98 Stool antigen test 44 42 6 6 88% 87.5% 88% 87.5%
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13C-urea is lower than the 14C-urea. Thus, the stool antigen test may be 
the only option of a non-invasive method of H. pylori eradication control 
in these Health Centers. 
The stool antigen test may be performed by conventional 
immunoassay (EIA) using polyclonal antibodies4,6,7,10,13,17, showing 
sensitivity of 88.9% to 98.3% and specificity of 77.8% to 98.4%, and by 
rapid lateral flow immunoassay using monoclonal antibodies10,12,14,15,33, 
presenting 52.5-94.6% sensitivity, 55.5-98.4% specificity, 94.6% positive 
predictive value and 98.4% of negative predictive value2,10,12,33. The lateral 
flow immunoassay is useful for small laboratories that do not have 
equipment for performing the EIA and that work with few samples. The 
lateral flow immunoassay is faster than the conventional EIA that takes 
more than two hours to be performed; in addition, the cut-off value is 
still a matter of debate2.33.
We tested rapid lateral flow immunoassay stool antigen (a commercial 
immunoassay kit of ACON), using the 13C-urea breath test as the gold 
standard method, and detected a sensitivity of 88% and specificity of 
87.5%, presenting good agreement with the breath test (κ = 0.755),  data 
consistent with those previously reported.
As the patients guaranteed that they had followed the instruction 
of avoiding proton pump inhibitors for at least ten days before the test, 
temporary inhibition of the growth would not be the cause of false-
negative results. Nonetheless, low colonization of bacteria in the stomach, 
and consequently, low concentration of antigens of H. pylori in the feces 
could not be enough to react in the test15, causing the false-negative tests. 
Coccoid form of H. pylori may explain the false-positive results that 
is the morphologic manifestation of bacterial cell death and does not 
mean an infection risk2; conversely, three patients with false-positive 
result were not eradication control; however, two of them had H. pylori-
positive relatives sharing the same bathroom. Even though patients were 
instructed to collect the stools in sterile vials supplied by the laboratory, 
we cannot exclude the possibility of external contamination. Another 
possibility would be cross-reaction among the polyclonal antibodies of 
the test with antigens of bacteria from the intestinal flora.
KRAUSSE et al. (2008)14 evaluated lateral flow rapid fecal antigen 
tests and found that the incubation time was an important factor for the 
reading of the result: readings at 30 min (76.9%) and 60 min (78.6%) 
had higher sensitivity than after 20 min (59.1), suggesting a new reading 
strategy: first interpretation at 15-20 min, and a long incubation of 30 
min when the sample is negative for up to 20 min. We also observed in 
some samples that turned up positive after 20 minutes of incubation (data 
not shown), that this strategy may increase sensitivity. 
We conclude that the lateral flow stool antigen test can be used as an 
alternative to breath test for diagnosis of primary infection of H. pylori, 
especially in developing countries.
RESUMO
Validação de teste rápido de antígeno fecal para diagnóstico 
de infecção por Helicobacter pylori
O objetivo desse trabalho foi avaliar o teste rápido de antígeno de H. 
pylori nas fezes (One step H. pylori antigen test, ACON laboratories, San 
Diego, USA; Prime diagnostics, São Paulo), usando teste respiratório 
com uréia marcada com 13C (TRU-13C), como padrão ouro. Noventa e 
oito pacientes assintomáticos ou com dispepsia participaram do estudo. 
Sessenta e nove eram mulheres; a média de idade dos pacientes foi de 
45.76 ± 14.59 (14 a 79 anos). No grupo H. pylori positivo, o teste rápido 
detectou antígenos de H. pylori nas fezes em 44 dos 50 pacientes positivos 
(sensibilidade de 88%; 95% IC: 75.7-95.5%), com seis falso-negativos; 
e no grupo H. pylori negativo, 42 apresentaram resultados negativos 
(especificidade de 87,5%; 95% IC: 74.7-95.3%), com seis falso-positivos, 
mostrando concordância substancial (índice Kappa = 0.75; p < 0.0001; 
95% IC: 0.6-0.9). Quarenta e quatro dos 50 que tiveram teste de antígeno 
fecal positivo eram H. pylori positivos, sendo o VPP do teste 88% (95% 
IC: 75.7-95.5%), e 42 pacientes com teste de antígeno fecal negativo 
eram H. pylori negativos, com VPN de 87,5% (95% IC: 74.7-95.3%). 
Concluímos que o teste de antígeno fecal imunocromatográfico pode ser 
usado como alternativa ao teste respiratório para diagnóstico de infecção 
pelo H. pylori, principalmente em países em desenvolvimento.
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